Entity > Corporation > US > New York City New York > Spero Therapeutics
About Spero Therapeutics
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Spero Therapeutics
| Company Attribute | Value |
| Address | StreetAddress: 675 Massachusetts Ave Fl 14, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2139, AddressCountry: United States |
| Founding Date | 2013 |
| Name | Spero Therapeutics |
| Number Of Employees | 35 |
| Revenue | $13,025,000 USD |
| Ticker Symbol | NASDAQ: SPRO |
| Url | sperotherapeutics |
| Wikidata | wikidata |
Spero Therapeutics
New York City, US
17 Sep 2023
Spero Therapeutics
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.sperotherapeutics.com/
Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for ...
Rich Sitelinks
People Also Ask
https://twitter.com/Spero_Tx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
https://finance.yahoo.com › quote › SPRO
Find the latest Spero Therapeutics, Inc. (SPRO) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.linkedin.com › company › spero-therape...
Oct 22, 2022 — We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for ...
https://www.cnbc.com › quotes › SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, and commercializing treatments ...
https://www.crunchbase.com › organization › spero-th...
Spero Therapeutics develops therapeutics for treatment of gram-negative infections. ... Spero Therapeutics raised to date? Spero Therapeutics has raised. $443.6M.
https://atlasventure.com › company › spero-therapeutics
Spero Therapeutics is developing novel therapies to treat highly resistant bacterial infections. The company is in partnership with Roche to develop its ...
https://www.pfizer.com › news › press-release-detail
Jun 30, 2021 — Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel ...
Related Searches
Spero therapeutics stock price
spero therapeutics address
spero therapeutics news
Knowledge Panel
Spero Therapeutics (Biotech company)
-
Stock price : SPRO (NASDAQ) $1.28 -0.01 (-0.78%)Sep 15, 4:00 PM EDT - Disclaimer
-
Headquarters : Massachusetts
-
Founded : 2013
-
President : Ankit Mahadevia
| Entity Home | Kalicube Pro Entity Page |